|
Catalog Number 8070117 |
Device Problem
Contamination (1120)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/29/2023 |
Event Type
malfunction
|
Event Description
|
On 01sep2023, the customer, sharp clinical services llc, contacted west pharma.Services, il ltd.(west il), to report that during reconstitution of a medication (sotatercept 60mg open label patient kits) to be administered subcutaneously, a gray particle was observed within the solution that could not be dissolved.As per photo provided, the customer could not precisely provide the dimensions of the particle, stated "perhaps 1-2mm".The vial adapter, along with the medication and diluent, were inspected before preparation started and there were no issues observed.A replacement product was prepared and administered.
|
|
Manufacturer Narrative
|
West pharma services il (west il) investigated a complaint received by sharp clinical services llc regarding a foreign particle observed within a vial of the reconstituted solution which could not be dissolved.The product was not returned to west il for evaluation.However, a photograph was provided to west il with a visible particle as reported inside of the vial.According to batch records review on lot number f547, it was manufactured according to relevant procedures, tested before release and shipped according to specifications.There were no related non-conformances found and no findings were observed.Additionally, no deviations in the production process were found.Retained samples from lot #f547 were visually inspected by the sub-contractor and no findings were observed.According to the customer, no samples are available for investigation.The described particle could not pass through the spike, since the dimensions of the particle reported as approximately 1-2mm, while the spike tip of the vial adapter has 3 windows and each window is 0.5mm.At this time, the root cause could not be determined.
|
|
Search Alerts/Recalls
|
|
|